Peptide library › Heart & blood
Terlipressin
Also known as Terlivaz, Glypressin
Hospital drug that improves kidney function in hepatorenal syndrome, a kidney failure caused by severe liver disease.
What people use it for
- Hepatorenal syndrome
- Bleeding from swollen gullet veins (outside the US)
What Terlipressin does in the body
A long-acting prodrug of vasopressin that tightens blood vessels in the gut. This redirects blood flow and improves blood supply to the kidneys.
Strength of evidence
Strong: the CONFIRM trial improved hepatorenal syndrome reversal versus placebo.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Breathing failure, especially with fluid overload
- Stomach pain and diarrhoea
- Reduced blood flow to fingers, toes or gut
Who should avoid it or take extra care
- Low blood oxygen
- Worsening breathing problems
- Used only by hospital teams
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved in 2022. Carries a boxed warning for serious or fatal breathing failure. Hospital use.
How it's taken
Route: Injection into a vein
How long it lasts (half-life): About 1 hour (its active product lasts longer)
Storage
Stored and prepared by the pharmacy or clinic, following the product label.
Keep track of Terlipressin privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Terlipressin in Fiala How to installMore in Heart & blood
- EnlicitideFirst daily tablet that blocks PCSK9 to lower LDL ("bad") cholesterol, a job that previously needed injections.
- Angiotensin IIIntensive-care drip that raises dangerously low blood pressure in shock when other drugs aren't enough.
- BivalirudinShort-acting blood thinner given by drip during heart procedures such as stenting.
- DesirudinLab-made leech-derived blood thinner once used to prevent clots after hip replacement; now discontinued in the US.
- EptifibatideHospital drip that stops platelets clumping during heart attacks and stenting.
- NesiritideLab-made heart hormone (BNP) once used by drip for sudden heart failure; now largely withdrawn.
- VasopressinNatural hormone given by drip in intensive care to raise blood pressure in shock.
- SelepressinExperimental vasopressin-like drug for septic shock that failed its main trial.
- DesmopressinSynthetic version of the water-retaining hormone, used for bedwetting, frequent night-time urination, diabetes insipidus and some bleeding disorders.
- RusfertideWeekly injection that mimics the iron hormone hepcidin to control red blood cell overproduction in polycythemia vera.
- PegcetacoplanComplement blocker used for the rare blood disease PNH (as an infusion under the skin) and for geographic atrophy in the eye (as an eye injection).